A candidate precursor to serous carcinoma that originates in the distal fallopian tube. - Wikidata - awgldk - TriplyDB

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

http://www.wikidata.org/entity/Q33264156

about

The detection, treatment, and biology of epithelial ovarian cancer Beyond CA125: the coming of age of ovarian cancer biomarkers Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy Origin and molecular pathogenesis of ovarian high-grade serous carcinoma EGFR/HER-targeted therapeutics in ovarian cancer Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer Salpingectomy as a means to reduce ovarian cancer risk The oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention"Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithelium-lined inclusion cysts or teratomas Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.Better therapeutic trials in ovarian cancer.Pathobiology of ovarian carcinomas Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4 Chlamydia trachomatis Genital Infections.The disparate origins of ovarian cancers: pathogenesis and prevention strategies.Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation.Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.Epithelial ovarian cancer - more data, more questions?Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity.Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells.Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53.Risk factors for epithelial ovarian cancer by histologic subtype.Expression signatures of TP53 mutations in serous ovarian cancers.The Müllerian HOXA10 gene promotes growth of ovarian surface epithelial cells by stimulating epithelial-stromal interactions Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma.Glucocorticoid-induced reversal of interleukin-1β-stimulated inflammatory gene expression in human oviductal cells.Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry?Role of CSF-1 in progression of epithelial ovarian cancer Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer

P2860

Q21198791-E2FF0F6D-E69A-486B-B0E1-EA4FBBB56343 Q24651567-CC9B9EBD-C9CC-4212-870A-D6069FF859A2 Q26747279-56376A65-12C4-44EC-80FA-722A6CB6FB54 Q26780387-ADDC11ED-CCF5-459F-B728-BA54FA3A200F Q26822545-5FE5861C-F895-453B-B362-A30D95F5138E Q26851347-AD301240-4E3E-4A1E-98DB-2AC7F4365469 Q26852698-4B90BADF-EA31-49EA-9B5E-40F021700694 Q26863231-996E6AD9-1834-485C-A289-549E02D5F8BD Q26998068-8950DA96-7529-4FEB-A231-8487C03806D2 Q27008375-CFFB0908-8EF7-48C9-A94B-85E1906CC82A Q27009306-4D16FC0D-95CF-4ADB-A631-EE34F6315DBB Q27011949-B88CD4F7-3A29-4B40-A22E-9C8AA7D8D433 Q27025315-7EC3AD5F-B369-4E68-A661-3EF91182E82C Q27317427-7F246D3E-A57E-4124-AE6D-1041677232C4 Q27333756-56DE4CB4-05DA-4FED-B5C1-4AD98D792670 Q27691432-C4428774-97AB-4DF0-AAA9-88AFDE2BBE6B Q28080478-D7FFD3D7-51FA-4F1F-9343-8F1FEEBDAAD2 Q28534173-859C2F88-E090-454C-8342-287D10624004 Q30235030-D84D3547-32E0-4152-9377-5395C0641080 Q30240709-7B217641-4A95-462F-8BEA-7B1F4B4BF599 Q30250107-9B921270-C5D8-4A4F-BBC6-89E755DDA1DB Q30423597-0AADF1E7-2771-4A32-AE3D-6A053185EAFF Q30430198-9A03E2C1-64BA-49C0-9AF3-4456ABB81579 Q30651522-C10388C7-2D06-4D8E-9ED0-8C7A15456EC3 Q30841262-956627B4-9757-40E8-B2C4-351AF1831850 Q30869183-72368D46-3A48-4294-A8C4-2C0EBF26045D Q31141440-87CE684F-0EAD-416D-8DE9-C965F2BA48E5 Q33431553-7DEC6628-A070-465D-90EA-6BEBDE070F71 Q33489525-3CEA55F2-C20F-4812-A07E-6A259D52DAC9 Q33510967-1443D1B9-86B9-4B77-8118-3EE58B54ED86 Q33521103-B3489F9E-4569-44B8-84E7-7D56FD17643C Q33521710-F67753DD-A8ED-4059-BCEF-7F5C1BC65188 Q33552610-FC6E390D-2AC1-4235-945A-A5F968188768 Q33588196-83405649-6970-4121-84FF-91F98F564847 Q33624201-0372FD6E-A751-410A-AB14-FE8570147CFC Q33633387-29039178-6B1F-45AF-94E1-13A0B91732CD Q33645478-9E7F335F-FC99-4331-8A9D-4A290DABF915 Q33687535-EBE0F7CA-17AB-4417-874B-8EAD89495365 Q33694369-41111DC7-5DE5-4866-A962-B724DECBF540 Q33704050-5FD8DB59-0BF1-459C-BCFA-726681C7329C

P2860

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

http://www.wikidata.org/entity/Q33264156

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

@ast

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

@en

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

@nl

type

label

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

@ast

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

@en

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

@nl

prefLabel

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

@ast

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

@en

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

@nl

P1433

Q33264156-27C44254-32BF-4051-8D47-647ACC336314

P1476

Q33264156-DD84FDEA-5BAF-449F-AE8B-FF7A9676C3C0

P2093

Q33264156-0408BC4F-2094-44A7-B672-9FD056B5D108

Q33264156-1500941A-4411-4903-92CF-07CB27531F4E

Q33264156-26512EEC-756E-46D0-882D-BC02703309D4

Q33264156-41F16DB1-4034-4512-9EE9-A1A262770BB5

Q33264156-5899330F-2DA7-4CDA-927E-1776F11CFE24

Q33264156-77916E78-2BA3-4C5E-897C-8AE7E715A223

Q33264156-A10E8996-D830-4929-A274-0E1BE9F88A2F

Q33264156-BB68E8B7-F102-40E1-A919-9156223FB5C9

Q33264156-C9F039DD-A72B-4C10-8FCB-83B51EADBE31

Q33264156-CF5E4F9B-FE86-42D4-A31D-5BB304903D94

P2860

Q33264156-88E7B8EB-AA97-413F-B4E2-6FBF271638B4

Q33264156-F77B20F5-E0D5-4A9A-A2FA-CEB74E658D49

Q33264156-FF8FC71A-4E36-4581-97E7-B6431AC88039

P304

Q33264156-F2F8DA38-D19D-48C5-B398-1910D38828D6

P31

Q33264156-07960A57-87AA-44FF-9A0B-4376AAD2DFBE

P356

Q33264156-250BA3FF-3BB2-4CDE-AA5A-3742F333BEBE

P433

Q33264156-52502441-496A-4F78-9518-DA98EEE7B854

P478

Q33264156-22D5F233-0E6F-400C-8BBE-1A0869DE3646

P50

Q33264156-D62B065B-7A05-4FFB-9552-422E4ACB0B34

P577

Q33264156-BA8BE1BE-AD18-4C6B-82FE-0FF90755725F

P5875

Q33264156-83147B9C-CC6E-4485-9072-825AFE984053

P698

Q33264156-3451FF27-375C-41CE-8E04-383F1EF5BD95

P921

Q33264156-83FC5CBF-1EB6-407E-A1F5-70BB8DE70CD8

P356

P1433

The Journal of Pathology

P1476

A candidate precursor to serous carcinoma that originates in the distal fallopian tube

@en

P2093

Birch C

http://www.w3.org/2001/XMLSchema#string

Cramer DW

http://www.w3.org/2001/XMLSchema#string

Crum CP

http://www.w3.org/2001/XMLSchema#string

Garber J

http://www.w3.org/2001/XMLSchema#string

Gordon RW

http://www.w3.org/2001/XMLSchema#string

Lee Y

http://www.w3.org/2001/XMLSchema#string

McKeon FD

http://www.w3.org/2001/XMLSchema#string

Medeiros F

http://www.w3.org/2001/XMLSchema#string

Miron A

http://www.w3.org/2001/XMLSchema#string

Mou H

http://www.w3.org/2001/XMLSchema#string

P2860

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

A high frequency of sequence alterations is due to formalin fixation of archival specimens.

BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?

P304

26-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.2091

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

211

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6681347

http://www.w3.org/2001/XMLSchema#string

P698

17117391

http://www.w3.org/2001/XMLSchema#string

P921